EUVIMEDEUVIMED entdecken
Crossref

Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression

Hiroyuki Minato, Ryo Endo, Yasutaka Kurata, Tomomi Notsu, Yoshiharu Kinugasa, Takayuki Wakimizu, Motokazu Tsuneto, Yasuaki Shirayoshi, Haruaki Ninomiya, Kazuhiro Yamamoto, Ichiro Hisatome, Akihiro Otsuki

Heart and Vessels · 2024

DOI: 10.1007/s00380-024-02415-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart and Vessels, 2024. Verfasst von Hiroyuki Minato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Tottori University Faculty of Medicine, 86 Nishi-Cho, Yonago, 683-8503, Japan. Hauptthemen laut MEDLINE: Dihydropyridines, Myocytes, Cardiac, Nitric Oxide, Azetidinecarboxylic Acid. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DihydropyridinesMyocytes, CardiacNitric OxideAzetidinecarboxylic AcidCalcium Channel BlockersApoptosisMyocardial Reperfusion InjuryAnimalsMiceGene Expression RegulationNitric Oxide Synthase Type IIIAction PotentialsCell HypoxiaCell Line

Stichwörter der Autor:innen

Action potentialAzelnidipineIschemia-reperfusionNORNA-seqeNOS

Substanzen

DihydropyridinesNitric OxideazelnidipineAzetidinecarboxylic AcidCalcium Channel BlockersNitric Oxide Synthase Type III

Autor:innen und Institutionen

  • Department of Anesthesiology, Tottori University Faculty of Medicine, 86 Nishi-Cho, Yonago, 683-8503, Japan.
  • Department of Physiology II, Kanazawa Medical University, Ishikawa, 920-0293, Japan. yasu@kanazawa-med.ac.jp.
  • Department of Genomic Medicine and Regenerative Therapy, Tottori University Faculty of Medicine, Yonago, 683-8503, Japan.
  • Department of Cardiovascular Medicine, and Endocrinology and Metabolism, Tottori University Faculty of Medicine, Yonago, 683-8503, Japan.
  • Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
  • Takeda-CiRA Joint Program (T-CiRA), Fujisawa, 251-8555, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Minato, H., Endo, R., Kurata, Y., Notsu, T., Kinugasa, Y., Wakimizu, T., Tsuneto, M., Shirayoshi, Y., Ninomiya, H., Yamamoto, K., Hisatome, I., & Otsuki, A. (2024). Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression. Heart and Vessels. https://doi.org/10.1007/s00380-024-02415-4

Vancouver

Minato H, Endo R, Kurata Y, Notsu T, Kinugasa Y, Wakimizu T, et al. Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression. Heart and Vessels. 2024. doi:10.1007/s00380-024-02415-4

BibTeX
@article{Minato2024,
  author = {Minato, Hiroyuki and Endo, Ryo and Kurata, Yasutaka and Notsu, Tomomi and Kinugasa, Yoshiharu and Wakimizu, Takayuki and Tsuneto, Motokazu and Shirayoshi, Yasuaki and Ninomiya, Haruaki and Yamamoto, Kazuhiro and Hisatome, Ichiro and Otsuki, Akihiro},
  title = {Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression},
  journal = {Heart and Vessels},
  year = {2024},
  doi = {10.1007/s00380-024-02415-4}
}
Kostenlos starten →